Loading…
Seda Pharmaceutical Development Services
Maximising your value through the integrated application of Pharmaceutical Development and Clinical Pharmacology expertise
About
Seda Pharmaceutical Development Services is a UK consultancy that integrates pharmaceutical development with clinical pharmacology, stating on its site that "Seda was founded in 2015 by pharmaceutical experts Paul Dickinson and Marcel de Matas". It offers consultancy, laboratory services (formulation screening and development) and modelling services, organised around product design, product performance, product authorisation and product supply. Stated areas of expertise include DMPK, dose selection, pharmacokinetic modelling, oral drug delivery, complex medicines, paediatric product development and CMC regulatory.
Deterministic scores · rules-based, not AIiHow these scores are obtained: each one is computed from this profile's listed attributes — capability checkboxes, certifications, capacity figures and coverage — by a fixed formula, recomputed on every page load. Deterministic and rules-based means the score comes from a fixed, transparent formula over listed attributes — the same inputs always produce the same score. It is not AI: there is no model, no learning, and no hidden weighting. Whether a score is relevant to you depends on your specific project: a capability that raises the number may not matter for your work, and a niche strength your project needs may barely move it. Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.
GMP expertise iAverages per-area depth across the consultant's listed GMP expertise areas - each area blends proficiency (Foundational 35 up to SME 100, 45%), years of experience (capped at 20, 25%), projects completed (capped at 40, 20%) and inspection support (10%) - then combines 78% depth with 22% breadth (14 points per area, ~7 areas = full breadth). Shows 0 - Developing with no areas listed. Levels: 85+ Elite | 70-84 Advanced | 50-69 Established | below 50 Developing. Whether this dimension matters for you depends on your specific project.
0Developing
Functional depth iAverages each functional specialization group - 60% its SME level (Practitioner 45 up to Authority 100) plus 40% its skill count (20 points per skill, capped) - then combines 75% depth with 25% breadth (17 points per group, ~6 groups = full breadth). Shows 0 - Developing with no groups listed. Levels: 85+ Authority | 70-84 Advanced | 50-69 Established | below 50 Developing. Whether this dimension matters for you depends on your specific project.
0Developing
Regulatory iAdds inspections supported (4 points each, capped at 40), remediations led including Warning-Letter and data-integrity work (5 points each, capped at 30) and regulatory agencies covered (5 points each, capped at 20), plus a 10-point credit for any Warning-Letter remediation. Levels: 80+ Authority | 60-79 Seasoned | 40-59 Experienced | below 40 Emerging. Whether this dimension matters for you depends on your specific project.
20Emerging
Engagement iHow fast and flexibly the consultant can start: availability status (Available now 35, Limited 22, otherwise 10), typical response time (same-day/24h 25, 48h 15, any stated time 8), engagement models offered (6 points each, capped at 25), plus 8 for remote availability and 7 for willingness to travel. Levels: 80+ Immediate | 60-79 Ready | 40-59 Available | below 40 Limited. Whether this dimension matters for you depends on your specific project.
10Limited
Audit readiness iCounts agencies with at least one supported inspection (FDA, EMA, MHRA, PMDA, Health Canada, WHO - 5 points each, capped at 25), total inspections and audits (1.2 points each, capped at 30), mock inspections (3 each, capped at 10), the reported inspection success rate (up to 20; assumed 70% if unreported) and remediations (2.5 each, capped at 15). Levels: 85+ Inspection-ready | 70-84 Strong | 50-69 Established | below 50 Developing. Whether this dimension matters for you depends on your specific project.
14Developing
Industry maturity iClinical-to-commercial lifecycle reach: commercial launches (6 points each, capped at 24), facility startups (3 each, capped at 18), greenfield plus brownfield projects (2.5 each, capped at 14), facilities supported (0.7 each, capped at 14) and manufacturing scales covered (3 each, capped at 12, plus 8 if commercial scale), plus 2 points per industry served, capped at 10. Levels: 85+ Commercial-grade | 70-84 Advanced | 50-69 Established | below 50 Emerging. Whether this dimension matters for you depends on your specific project.
0Emerging
Regulatory agencies
Seda states that specialist CMC regulatory consultants are available "including an ex-MHRA Assessor"and that it supports regulatory agency interactionsbriefing materials and face-to-face representationphase-appropriate regulatory strategyQbD and control-strategy developmentand clinically relevant dissolution specifications. GMP manufacturing and testing is offered through a linked sister operationSeda Clinical Manufacturing Services (sedacms.com). No ISO certification and no GMP or manufacturing licence is claimed for the consultancy entity itself on the pages reviewedso no capability flags were set.
Primary specializations
Oral drug deliveryDMPK consultancyPharmacokinetic modellingComplex medicinesPaediatric product developmentCMC regulatoryClinical pharmacologyLaboratory servicesGMP manufacturing
Coverage regions
UK head office at Unit 4 Oakfield RoadCheadle Royal Business ParkCheadleStockportGreater Manchester SK8 3GX; a Sweden office at Medicon VillageSE-223 81 Lund.
Seda Pharmaceutical Development Services
Maximising your value through the integrated application of Pharmaceutical Development and Clinical Pharmacology expertise
Live record · illustrative seed data · scores deterministic, rules-based — not AI.